- Laboratory
- Laboratory medicine
- Rapid flu test
- LifeSign PBM
COVID-19 rapid test Status™flufor antigensSARS-COV-2
Add to favorites
Compare this product
Characteristics
- Pathology
- COVID-19, flu
- Tested parameter
- for antigens
- Micro-organism
- SARS-COV-2
- Sample type
- nasal, nasopharyngeal
- Analysis mode
- immunoassay
- Result display time
15 min
- Specificity
95.7 %, 95.9 %, 100 %
- Sensitivity
87.6 %, 91.4 %, 93.1 %, 93.8 %
Description
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens
FDA Emergency Use Authorization (EUA)
Flocked nasopharyngeal swab for superior specimen collection and patient comfort
VIDEO
Catalogs
Related Searches
- Assay kit
- Blood assay kit
- Serum assay kit
- Immunoassay assay kit
- Plasma assay kit
- Infectious disease detection kit
- Blood rapid diagnostic test
- Rapid lateral flow test
- Immunoassay rapid diagnostic test
- Cassette rapid diagnostic test
- Whole blood detection kit
- Rapid virus test
- Serum rapid diagnostic test
- Plasma rapid diagnostic test
- Infectious disease rapid diagnostic test
- Whole blood rapid diagnostic test
- Rapid respiratory infection test
- Urine rapid diagnostic test
- COVID-19 rapid diagnostic test
- Bacteria rapid diagnostic test
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.